JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2019, 68(2):78-85 | DOI: 10.36290/csf.2019.010

OTC market - comparing Czech Republic and Greece

Božena Macešková*, Marios-Panagiotis Tsadaris, Michail Machlis
Department of Applied Pharmacy, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, CR

Medicines for self-medication (over-the-counter, OTC) are available through pharmacies, in some countries they are also available in supermarkets and other outlets. The use of OTC in European Union countries shows some differences at national level, in pharmacies and in patients' preference. This study aimed to completing the lists of marketed OTC in Czech Republic and Greece. Next topics are: finding out the real range of OTC products offered by pharmacies, finding and evaluating number of packages sold in pharmacies in 20 particular common OTC in 2016, and indentification of factors influencing the sales. Web pages of national drug authorities (Czech Republic, Greece) were searched to complete lists of marketed OTC in each country. Data on range of OTC drugs and sales of them were extracted from computer systems (Czech Republic) and other types of documents (Greece) kept in pharmacies. The percentage of the real range of OTC products in pharmacies was calculated as the ratio to the number of OTC in national lists. Numbers of sold packages were compared among pharmacies. Classification system ATC (anatomical/therapeutical/chemical) was employed to present findings in all parts of the research. The Czech list contained 1,160 of marketed OTC in 10 ATC (1st level), with the maximum in ATC R (243 drugs). The Greek list contained 1,254 OTC in 13 ATC (1st level), with the maximum in ATC D (272 drugs). In lists of both countries, there were detected 86 drugs identical in 9 ATC (1st level). At least one OTC in each of 10 listed ATC was found in Czech pharmacies as a part of range of products, the range of OTC in Greek pharmacies comprised 11 ATC. The highest sales (year 2016) were found in ATC R (drug ACC long tbl eff) in CR and in ATC A (drug: Imodium cps) in Greece. The differences in the range of OTC drugs and in their sales were found between Czech Republic and Greece, and between types of pharmacies inside each country. Factors influencing them were detected: ownership of the pharmacy, locality (number of inhabitants).

Keywords: OTC drugs; pharmacy; Czech Republic; Greece

Received: March 11, 2019; Accepted: April 24, 2019; Published: February 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macešková B, Tsadaris M, Machlis M. OTC market - comparing Czech Republic and Greece. Čes. slov. farm. 2019;68(2):78-85. doi: 10.36290/csf.2019.010.
Download citation

References

  1. What is selfmedication. http://www.wsmi.org/about-self-care-and-self-medication/what-is-self-medication/ (1. 2. 2019).
  2. Statistics on OTC use. https://www.chpa.org/MarketStats.aspx#access (1. 2. 2019).
  3. Better regulation of nonprescription medicines. http://www.aesgp.eu/publications/wsmi-publications/ (1. 2. 2019).
  4. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use.
  5. Minghetti P., Casiraghi A., Cilurzo F., Montanari L. The situation of OTC drugs in Italy compared to the other EU states. Pharmacol. Res. 2000; 42(1), 25-31. Go to original source... Go to PubMed...
  6. AESPG Annual Report 2015-2016. http://www.aesgp.eu/publications/library/ (1. 2. 2019).
  7. Vogler S., Arts D., Sandberger K. Impact of pharmacy deregulation and regulation in European countries (2012). https://ppri.goeg.at/technical_reports (1. 2. 2019).
  8. Market access in the Czech Republic. http://www.pmlive.com/pharma_news/market_access_czech_republic_356414 (1. 2. 2019).
  9. http://www.sukl.eu/medicines/marketing-authorisation-of-pharmaceuticals (1. 2. 2019).
  10. Market data. Total non- prescriptions medicines market sales. http://www.aesgp.eu/facts-figures/market-data/non-prescription-market/ (1. 2. 2019).
  11. OECD Health Working Paper No.87. Pharmaceutical expenditure and policies: past trends and future challenges. https://www.oecd-ilibrary.org/social-issues-migration-health/pharmaceutical-expenditure-and-policies_5jm0q1f4cdq7-en (1. 2. 2019).
  12. Health at a Glance 2017. https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-en (1. 2. 2019).
  13. Product, Market and Regulatory Pathway Strategy. https://www.freyrsolutions.com/regulatory-services-in-greece (1. 2. 2019).
  14. Healthcare Resource Guide: Greece. https://build.export.gov/main/industry/health/healthcareresourceguide/eg_main_092012 (1. 2. 2019).
  15. Kontos N. Are OTC's in Greece stepping into the new era? https://www.linkedin.com/pulse/otcs-greece-stepping-new-era-nikos-kontos/ (1. 2. 2019).
  16. Greek Ministry of Health. Creating of drug subcategory ΓΕ.ΔΙ.ΦΑ http://www.moh.gov.gr/articles/ministry/grafeio-typoy/press-releases/3917 (1. 2. 2019).
  17. Greece: Pharmaceutical advertising 2018. https://iclg.com/practice-areas/pharmaceutical-advertising-laws-and-regulations/greece (1. 2. 2019).
  18. Active substances belonging to the subcategory ΓΕ.ΔΙ.ΦΑ https://www.farmakeutikoskosmos.gr/article-f/ayth-einai-h-lista-me-tis-drastikes-oysi/17898 (1. 2. 2019).
  19. Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to some Related Acts.
  20. http://www.sukl.cz/modules/medication/search.php (16. 10. 2016).
  21. http://www.eof.gr (18. 10. 2016).
  22. https://www.galinos.gr (18. 10. 2016).
  23. AISLP 2018.3 (Automated System of Medical Preparations, version 2018.3) https://www.aislp.cz/ (1. 2. 2019).




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.